Recent Updates
Recently added Catalysts
AMGN Positive Sentiment

AMGEN ANNOUNCES WEBCAST OF 2025 THIRD QUARTER FINANCIAL RESULTS

Key Takeaway: Amgen has announced it will report its third quarter 2025 financial results on November 4, 2025. Following the report, a conference call will be held at 4:30 p.m. ET with key executives, including CEO Robert A. Bradway. The call will be accessible via a live webcast, which will also be archived for later viewing.
Price reaction · baseline $291.77 (2025-10-29 close) · hit after-hours · 3 other AMGN headline(s) in the window, move may be shared
day 0 close
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Amgen continues to demonstrate transparency by announcing financial results.
  • The webcast allows broad access to financial information for investors and the public.
  • Amgen's innovative reputation is reinforced by its ongoing developments and recognitions.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+30%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Maridebart cafraglutide
Phase 3 · Heart Failure With Preserved Ejection Fraction

Full Press Release Details

THOUSAND OAKS, Calif.,Oct. 29, 2025/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its third quarter 2025 financial results on Tuesday, November 4, 2025, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.
Live audio of the conference call will be simultaneously broadcast over the internet and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website,www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About AmgenAmgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among otherexternal recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visitAmgen.comand follow Amgen onX,LinkedIn,Instagram,YouTubeandThreads.

Frequently Asked Questions

When will Amgen report its Q3 2025 financial results?

Amgen will report its Q3 2025 financial results on November 4, 2025.

What time is the conference call for Amgen's results?

The conference call will take place at 4:30 p.m. ET.

Who will participate in the conference call?

CEO Robert A. Bradway and other senior management will participate.

How can I access the webcast of the conference call?

The webcast will be available on Amgen's website and archived for 90 days.

Last updated: Oct 29, 2025